Spire Wealth Management Embecta Corp. Transaction History

Spire Wealth Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$12.35 - $19.33 $345 - $541	-28 Reduced 41.79%	39 $0
Q4 2023 Feb 06, 2024	SELL	$12.87 - $19.09 $141 - $209	-11 Reduced 14.1%	67 $1,000
Q3 2023 Nov 08, 2023	SELL	$15.0 - $22.17 $705 - $1,041	-47 Reduced 37.6%	78 $1,000
Q2 2023 Aug 09, 2023	SELL	$21.6 - $30.69 $43 - $61	-2 Reduced 1.57%	125 $2,000
Q1 2023 May 09, 2023	BUY	$23.07 - $32.77 $1,499 - $2,130	65 Added 104.84%	127 $3,000
Q4 2022 Feb 03, 2023	SELL	$25.29 - $35.48 $657 - $922	-26 Reduced 29.55%	62 $2,000
Q3 2022 Nov 07, 2022	SELL	$24.0 - $33.42 $7,104 - $9,892	-296 Reduced 77.08%	88 $3,000
Q2 2022 Jul 22, 2022	BUY	$24.78 - $33.36 $9,515 - $12,810	384 New	384 $10,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.